Purchase Order 75D30119P06335
Award Date 9/20/19
Potential Completion Date 9/19/24
Potential Value $87K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $114,707.80 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the provision of laboratory supplies. The contract has no set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics and laboratory equipment, has a history of providing critical care analyzers, reagents, test kits, and associated supplies and services to various federal agencies, including the...
- This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
- This $139,966.72 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagent testing supplies and does not have a set-aside designation. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract has a ceiling value of $75,000.00 and was awarded on December 5, 2016 with a completion date of November 12, 2020. The award does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers,...
- This is a federal contract award by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, for a service agreement to provide laboratory instruments. The fixed-price purchase order has a ceiling value of $79,756.08 and an ultimate completion date of September 3, 2020. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, has previously received awards from various federal agencies including the Department of...
- This federal contract award with ID HHSD2002017M92821P was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $99,695.80 firm fixed price purchase order is for Roche lab equipment and supplies, with a completion date of January 27, 2017. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and other...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $108,800.00, is for preventative maintenance services to be performed by March 31, 2028. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment,...
- This firm fixed price purchase order for $77,096.13 was awarded on June 4, 2022 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents. The contract does not have a set-aside designation. Roche Diagnostics Corp will provide the reagents to the CDC by September 30, 2022. Roche Diagnostics holds multiple General Services Administration Schedule contracts and...
This is a $86,944 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for a ROCHE SERVICE AGREEMENT with a period of performance through September 2024. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies through its General Services Administration (GSA) Schedule contracts as well as through subcontract awards. This contract does not have a set-aside designation.
Generated 4/1/25, 8:57 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Additional Work (new agreement, FAR part 6 applies) | $0 | 11/30/22 | |
| Not listed | Not listed | $17.4k | 8/15/19 |